Eisai (OTCMKTS:ESALY) Share Price Crosses Below 50 Day Moving Average – Here’s Why
by Amy Steele · The Cerbat GemEisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares trading hands.
Eisai Stock Down 2.1%
The firm has a market cap of $17.64 billion, a P/E ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. The stock’s 50 day simple moving average is $61.51 and its 200 day simple moving average is $61.51. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.77 and a current ratio of 2.20.
Eisai Company Profile
Eisai Co, Ltd. is a Japan-based pharmaceutical company focused on discovering, developing and commercializing prescription medicines. Its research and commercial activities primarily address neurology, oncology and related areas of unmet medical need, with an emphasis on improving patient care and quality of life.
The company’s portfolio includes treatments such as Leqembi (lecanemab), an Alzheimer’s disease therapy developed in collaboration with Biogen; Lenvima (lenvatinib), an oncology medicine developed with Merck; Halaven (eribulin) for certain cancers; Fycompa (perampanel) for epilepsy; and Dayvigo (lemborexant) for insomnia.